Patents by Inventor Klaus Bartsch

Klaus Bartsch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6210934
    Abstract: The preparation of L-2-amino-4-methylphosphinobutyric acid (L-PPT) by transamination of (3-carboxy-3-oxo-propyl)-methylphosphinic acid with the aid of the L-PPT-specific transaminase from E. coli DH 1 is very much more efficient when the gene coding for this enzyme is isolated, incorporated into the plasmid and then a microorganism is transformed therewith.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 3, 2001
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Klaus Bartsch, Arno Schulz, Eugen Uhlmann
  • Patent number: 6177616
    Abstract: The invention relates to DNA molecules which code for deacetylases or proteins having the biological activity of a deacetylase and also transgenic plant cells which were transformed using the DNA molecules according to the invention. These molecules can be used for the production of plants having specifically destroyable parts, i.e. male- or female-sterile plants, by means of the specific expression of a deacetylase gene.
    Type: Grant
    Filed: June 14, 1999
    Date of Patent: January 23, 2001
    Assignee: Hoecsht Schering Agrevo GmbH
    Inventors: Klaus Bartsch, Guido Kriete, Inge Broer, Alfred P{umlaut over (u)}hler
  • Patent number: 6051408
    Abstract: The preparation of L-2-amino-4-methylphosphinobutyric acid (L-PPT) by transamination of (3-carboxy-3-oxopropyl)-methylphosphinic acid with the aid of the L-PPT-specific transaminase from E. coli DH 1 is very much more efficient when the gene coding for this enzyme is isolated, incorporated into a plasmid and then a microorganism is transformed therewith.
    Type: Grant
    Filed: November 26, 1997
    Date of Patent: April 18, 2000
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Klaus Bartsch, Arno Schulz, Eugen Uhlmann
  • Patent number: 5962281
    Abstract: L-tertiary-Leucine and L-phosphinothricine are obtainable by transamination of the corresponding keto acids as a precursor in the presence of amino acids as amino group donors. The reaction is preferably carried out with microorganisms or their transaminases.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: October 5, 1999
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Johann Then, Klaus Bartsch, Hans-Matthias Deger, Susanne Grabley, Rudiger Marquardt
  • Patent number: 5919669
    Abstract: L-tertiary-Leucine and L-phosphinothricine are obtainable by transamination of the corresponding keto acids as a precursor in the presence of amino acids as amino group donors. The reaction is preferably carried out with microorganisms or their transaminases.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: July 6, 1999
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Johann Then, Klaus Bartsch, Hans-Matthias Deger, Susanne Grabley, Rudiger Marquardt
  • Patent number: 5888782
    Abstract: A gene and gene structure coding for an aminotransferase, and microorganisms which express this gene.The preparation of L-2-amino-4-methylphosphinobutyric acid (L-PPT) by transamination of (3-carboxy-3-oxopropyl)-methylphosphinic acid with the aid of the L-PPT-specific transaminase from E. coli DH 1 is very much more efficient when the gene coding for this enzyme is isolated, incorporated into a plasmid and then a microorganism is transformed therewith.
    Type: Grant
    Filed: November 4, 1994
    Date of Patent: March 30, 1999
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Klaus Bartsch, Arno Schulz, Eugen Uhlmann
  • Patent number: 5879903
    Abstract: Selection of Streptomyces viridochromogenes DSM 4112 for resistance to phosphinothricyl-alanyl-alanine (PTT) results in PTT-resistance selectants. The DNA fragment which carries the phosphinothricin(PTC)-resistance gene is obtained from the total DNA of these selectants by cutting with BamHI, cloning of a fragment 4.0 kb in size, and selection for PTT resistance. This gene is suitable for the production of PTC-resistant plants, and as a resistance marker and for the selective N-acetylation of the L-form of racemic PTC.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 9, 1999
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Eckhard Strauch, Wolfgang Wohlleben, Walter Arnold, Renate Alijah, Alfred Puhler, Gerhard Wohner, Rudiger Marquardt, Susanne Grabley, Dieter Brauer, Klaus Bartsch
  • Patent number: 5767371
    Abstract: Deacetylase genes for the production of phosphinothricin or phosphinothricyl-alanyl-alanine, processes for their isolation, and their use.The invention relates to deacetylase genes, to processes for their isolation, and to their use, in particular for the production of transgenic plants using tissue-specific promoters. It is possible to prevent the development of certain parts in these plants in a targeted manner. With the aid of deacetylase genes, it is furthermore possible to identify and isolate tissue-specific promoters in transgenic plants.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: June 16, 1998
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Inge Broer, Doris Hillemann, Alfred Puhler, Wolfgang Wohlleben, Gunter Donn, Hubert Mullner, Klaus Bartsch
  • Patent number: 5767370
    Abstract: Deacetylase genes for the production of phosphinothricin or phosphinothricyl-alanyl-alanine, processes for their isolation, and their use.The invention relates to deacetylase genes, to processes for their isolation, and to their use, in particular for the production of transgenic plants using tissue-specific promoters. It is possible to prevent the development of certain parts in these plants in a targeted manner. With the aid of deacetylase genes, it is furthermore possible to identify and isolate tissue-specific promoters in transgenic plants.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: June 16, 1998
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Inge Broer, Doris Hillemann, Alfred Puhler, Wolfgang Wohlleben, Gunter Donn, Hubert Mullner, Klaus Bartsch
  • Patent number: 5753470
    Abstract: L-tertiary-Leucine and L-phosphinothricine are obtainable by transamination of the corresponding keto acids as a precursor in the presence of amino acids as amino group donors. The reaction is preferably carried out with microorganisms or their transaminases.
    Type: Grant
    Filed: March 27, 1995
    Date of Patent: May 19, 1998
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Johann Then, Klaus Bartsch, Hans-Matthias Deger, Susanne Grabley, Rudiger Marquardt
  • Patent number: 5668297
    Abstract: The invention relates to deacetylase genes, to processes for their isolation, and to their use, in particular for the production of transgenic plants using tissue-specific promoters. It is possible to prevent the development of certain parts in these plants in a targeted manner. With the aid of deacetylase genes, it is furthermore possible to identify and isolate tissue-specific promoters in transgenic plants.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: September 16, 1997
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Inge Broer, Doris Hillemann, Alfred Puhler, Wolfgang Wohlleben, Gunter Donn, Hubert Mullner, Klaus Bartsch
  • Patent number: 5650310
    Abstract: The invention relates to deacetylase genes, to processes for their isolation, and to their use, in particular for the production of transgenic plants using tissue-specific promoters. It is possible to prevent the development of certain parts in these plants in a targeted manner. With the aid of deacetylase genes, it is furthermore possible to identify and isolate tissue-specific promoters in transgenic plants.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: July 22, 1997
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Inge Broer, Doris Hillemann, Alfred Puhler, Wolfgang Wohlleben, Gunter Donn, Hubert Mullner, Klaus Bartsch
  • Patent number: 5637489
    Abstract: Selection of Streptomyces viridochromogenes DSM 4112 for resistance to phosphinothricyl-alanyl-alanine (PTT) results in PTT-resistance selectants. The DNA fragment which carries the phosphinothricin(PTC)-resistance gene is obtained from the total DNA of these selectants by cutting with BamHI, cloning of a fragment 4.0 kb in size, and selection for PTT resistance. This gene is suitable for the production of PTC-resistant plants, and as a resistance marker and for the selective N-acetylation of the L-form of racemic PTC.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 10, 1997
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Eckhard Strauch, Wolfgang Wohlleben, Walter Arnold, Renate Alijah, Alfred Puhler, Gerhard Wohner, Rudiger Marquardt, Susanne Grabley, Dieter Brauer, Klaus Bartsch
  • Patent number: 5618728
    Abstract: Process for the enzymatic separation of phosphinothricin derivatives, which comprises treating a mixture of D- and L-phosphinothricin derivatives of the formulae (I) and (II) ##STR1## with a hydrolytically active enzyme in an aqueous or aqueous-organic medium.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 8, 1997
    Assignee: Hoechst Schering AgrEvo GmbH
    Inventors: Lothar Willms, Klaus Bartsch
  • Patent number: 5273894
    Abstract: Selection of Streptomyces viridochromogenes DSM 4112 for resistance to phosphinothricyl-alanyl-alanine (PTT) results in PTT-resistance selectants. The DNA fragment which carries the phosphinothricin(PTC)-resistance gene is obtained from the total DNA of these selectants by cutting with BamHI, cloning of a fragment 4.0 kb in size, and selection for PTT resistance. This gene is suitable for the production of PTC-resistant plants, and as a resistance marker and for the selective N-acetylation of the L-form of racemic PTC.
    Type: Grant
    Filed: November 20, 1991
    Date of Patent: December 28, 1993
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Eckhard Strauch, Wolfgang Wohlleben, Walter Arnold, Renate Alijah, Alfred Puhler, Gerhard Wohner, Rudiger Marquardt, Susanne Grabley, Dieter Brauer, Klaus Bartsch
  • Patent number: 5221737
    Abstract: A gene and gene structure coding for an aminotransferase, and microorganisms which express this gene The preparation of L-2-amino-4-methylphosphinobutyric acid (L-PPT) by transamination of (3-carboxy-3-oxopropyl)-methylphosphinic acid with the aid of the L-PPT-specific transaminase from E. coli DH 1 is very much more efficient when the gene coding for this enzyme is isolated, incorporated into a plasmid and then a microorganism is transformed therewith.
    Type: Grant
    Filed: December 13, 1989
    Date of Patent: June 22, 1993
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Klaus Bartsch, Arno Schulz, Eugen Uhlmann
  • Patent number: 5162212
    Abstract: A new transaminase has been isolated from E. coli DH-1 (ATCC 33849). It is possible to use the transaminase with great efficiency to prepare L-phosphinothricin and gamma-aminobutyric acid from appropriate precursors by transferring an amino group from glutamate.
    Type: Grant
    Filed: March 20, 1992
    Date of Patent: November 10, 1992
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Arno Schulz, Klaus Bartsch, Dominique Tripier, Klaus Sauber
  • Patent number: 5130246
    Abstract: A process for the preparation of a purified transaminase having a molecular weight of 20,000 to 250,000 daltons, an isoelectric point at a pH between 3.0 and 8.0, a pH optimum in a range from 5.0 to 10.0 and a substrate specificity for the transamination of (3-carboxy-3-oxo-propyl)-methyl-phosphinic acid or the esters thereof.The production of the enzyme comprises cultivating E. coli ATCC 33849, disrupting the cultivated E. coli ATCC 33849, obtaining a supernatant therefrom containing the enzyme and isolating the transaminase by heating the supernatant at a temperature and for a time sufficient to denature proteins other than the transaminase and than finally removing the denatured proteins from the supernatant.
    Type: Grant
    Filed: June 1, 1989
    Date of Patent: July 14, 1992
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Arno Schulz, Klaus Bartsch, Dominique Tripier, Klaus Sauber
  • Patent number: 5077399
    Abstract: Phosphinothricin (PTC) selection of bacteria which are not fungus-like yields PTC-resistant selectants. The DNA fragment which carries the resistance gene is obtained from the complete DNA of these selectants by constructing a gene bank and screening for chemical modification of PTC. The resistance gene can be localized to a fragment which is 2 kb in size, and selection for PTC resistance. This gene is suitable for producing PTC-resistant plants and propagation material thereof, and as a resistance marker as well. Microorganisms which contain this PTC-resistance gene can be used in sewage treatment plants.
    Type: Grant
    Filed: April 27, 1990
    Date of Patent: December 31, 1991
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Dieter Brauer, Klaus Bartsch, Gunter Donn
  • Patent number: 4852768
    Abstract: A dosing syringe has a cylindrical syringe body which at its tapering end has a dispensing orifice and at its other end a stepped cylindrical enlargement with two opposing handles. A recess is located below each handle, and a piston is inserted into the cylindrical syringe body. The piston is in contact with a dosing plunger having an external thread. Two threaded sides are arranged around the plunger and each threaded side has a positioning projection introduced into the recesses of the enlargement. According to the invention, the piston is connected to the dosing plunger by a spring retainer connection and the threaded sides have an outside groove in which an O-ring is inserted in countersunk fashion to hold the two threaded sides together. As a result, the piston-dosing unit can be prefabricated and introduced as a complete unit including the threaded sides into the enlargement of the syringe body where it is fixed simplifying the production technology of the dosing syringe.
    Type: Grant
    Filed: March 22, 1988
    Date of Patent: August 1, 1989
    Assignee: Blendax-Werke R. Schneider GmbH & Co.
    Inventor: Klaus Bartsch